↓ Skip to main content

Scaling up production of recombinant human basic fibroblast growth factor in an Escherichia coli BL21(DE3) plysS strain and evaluation of its pro-wound healing efficacy

Overview of attention for article published in Frontiers in Pharmacology, February 2024
Altmetric Badge

Mentioned by

twitter
1 X user